Last 12 months
Inside the activity.
0 purchase rows · 202 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 39 |
| Dec 2025 | 0 | 21 |
| Jan 2026 | 0 | 42 |
| Feb 2026 | 0 | 14 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 0 | 7 |
| May 2026 | 0 | 10 |
| Jun 2026 | 0 | 18 |
| Jul 2026 | 0 | 20 |
| Aug 2026 | 0 | 12 |
| Sep 2026 | 0 | 8 |
| Oct 2026 | 0 | 5 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 25, 2019 Filed Jan 29, 2019 21:15 UTC |
SCHMERTZLER MICHAELDirector
|
PurchaseCommon Stock | 66,225 | $30.20 | $1,999,995.00 |
DisclosureSEC source: 0001104659-19-004057 · a4.xml · nonDerivative · entry 2 SCHMERTZLER MICHAEL · CIK 0001288952 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,386,594 F1 · ownership.nature: Represents shares of common stock held by Section Six Partners, L.P. This Form 4 reports 66,225 shares of common stock purchased by Section Six Partners, L.P. in the Issuer's registered public offering on January 25, 2019. The reporting person is a general and limited partner of Section Six Partners, L.P. The reporting person disclaims beneficial ownership of the shares of common stock held by Section Six Partners, L.P. except to the extent of his pecuniary interest therein. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 22:53 UTC |
Utter Christine MariePrincipal Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 10,100 | $0.00 Strike: $33.02 | $0.00 |
DisclosureSEC source: 0001104659-19-003208 · a4.xml · derivative · entry 2 Utter Christine Marie · CIK 0001707685 · Principal Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,100 Underlying: Common Stock · 10,100 shares Expires 2029-01-21 F2 · derivative.exercise_date: This option was granted on January 22, 2019 and vests over four years, with 50% of the shares underlying the option vesting on January 22, 2022, and the remaining 50% of the original number of shares underlying the option vesting on January 22, 2023. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 22:53 UTC |
Utter Christine MariePrincipal Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 42,500 | $0.00 Strike: $33.02 | $0.00 |
DisclosureSEC source: 0001104659-19-003208 · a4.xml · derivative · entry 1 Utter Christine Marie · CIK 0001707685 · Principal Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,500 Underlying: Common Stock · 42,500 shares Expires 2029-01-21 F1 · derivative.exercise_date: This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 22:53 UTC |
Boulding Mark ElliottExec. VP and CLO
|
GrantStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $33.02 | $0.00 |
DisclosureSEC source: 0001104659-19-003207 · a4.xml · derivative · entry 2 Boulding Mark Elliott · CIK 0001578852 · Exec. VP and CLO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Common Stock · 17,500 shares Expires 2029-01-21 F2 · derivative.exercise_date: This option was granted on January 22, 2019 and vests over four years, with 50% of the shares underlying the option vesting on January 22, 2022, and the remaining 50% of the original number of shares underlying the option vesting on January 22, 2023. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 22:53 UTC |
Boulding Mark ElliottExec. VP and CLO
|
GrantStock Option (Right to Buy) · Derivative | 72,500 | $0.00 Strike: $33.02 | $0.00 |
DisclosureSEC source: 0001104659-19-003207 · a4.xml · derivative · entry 1 Boulding Mark Elliott · CIK 0001578852 · Exec. VP and CLO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,500 Underlying: Common Stock · 72,500 shares Expires 2029-01-21 F1 · derivative.exercise_date: This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 22:53 UTC |
SCHMERTZLER MICHAELDirector
|
GrantStock Option (Right to Buy) · Derivative | 28,000 | $0.00 Strike: $33.02 | $0.00 |
DisclosureSEC source: 0001104659-19-003206 · a4.xml · derivative · entry 1 SCHMERTZLER MICHAEL · CIK 0001288952 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,000 Underlying: Common Stock · 28,000 shares Expires 2029-01-21 F1 · derivative.exercise_date: This option was granted on January 22, 2019 and vests over one year in twelve equal monthly installments, commencing on February 22, 2019. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 22:52 UTC |
STEELE GLENN JR MD PHDDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,000 | $0.00 Strike: $33.02 | $0.00 |
DisclosureSEC source: 0001104659-19-003205 · a4.xml · derivative · entry 1 STEELE GLENN JR MD PHD · CIK 0001269131 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2029-01-21 F1 · derivative.exercise_date: This option was granted on January 22, 2019 and vests over one year in twelve equal monthly installments, commencing on February 22, 2019. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 22:50 UTC |
Svoronos DawnDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,000 | $0.00 Strike: $33.02 | $0.00 |
DisclosureSEC source: 0001104659-19-003204 · a4.xml · derivative · entry 1 Svoronos Dawn · CIK 0001574579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2029-01-21 F1 · derivative.exercise_date: This option was granted on January 22, 2019 and vests over one year in twelve equal monthly installments, commencing on February 22, 2019. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 22:50 UTC |
Okey StephanieDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,000 | $0.00 Strike: $33.02 | $0.00 |
DisclosureSEC source: 0001104659-19-003203 · a4.xml · derivative · entry 1 Okey Stephanie · CIK 0001742616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2029-01-21 F1 · derivative.exercise_date: This option was granted on January 22, 2019 and vests over one year in twelve equal monthly installments, commencing on February 22, 2019. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 22:48 UTC |
Reeve EmmaDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,000 | $0.00 Strike: $33.02 | $0.00 |
DisclosureSEC source: 0001104659-19-003201 · a4.xml · derivative · entry 1 Reeve Emma · CIK 0001680329 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2029-01-21 F1 · derivative.exercise_date: This option was granted on January 22, 2019 and vests over one year in twelve equal monthly installments, commencing on February 22, 2019. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 22:50 UTC |
ZELDIS JEROME BDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,000 | $0.00 Strike: $33.02 | $0.00 |
DisclosureSEC source: 0001104659-19-003202 · a4.xml · derivative · entry 1 ZELDIS JEROME B · CIK 0001433982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2029-01-21 F1 · derivative.exercise_date: This option was granted on January 22, 2019 and vests over one year in twelve equal monthly installments, commencing on February 22, 2019. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 22:47 UTC |
SOUTHWELL DAVID PDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,000 | $0.00 Strike: $33.02 | $0.00 |
DisclosureSEC source: 0001104659-19-003200 · a4.xml · derivative · entry 1 SOUTHWELL DAVID P · CIK 0001251553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2029-01-21 F1 · derivative.exercise_date: This option was granted on January 22, 2019 and vests over one year in twelve equal monthly installments, commencing on February 22, 2019. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 22:47 UTC |
Jacobson Allan StevenDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,000 | $0.00 Strike: $33.02 | $0.00 |
DisclosureSEC source: 0001104659-19-003199 · a4.xml · derivative · entry 1 Jacobson Allan Steven · CIK 0001579003 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2029-01-21 F1 · derivative.exercise_date: This option was granted on January 22, 2019 and vests over one year in twelve equal monthly installments, commencing on February 22, 2019. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 22:46 UTC |
Peltz Stuart WalterDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 26,950 | $0.00 Strike: $33.02 | $0.00 |
DisclosureSEC source: 0001104659-19-003198 · a4.xml · derivative · entry 4 Peltz Stuart Walter · CIK 0001578962 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 26,950 Underlying: Common Stock · 26,950 shares Expires 2029-01-21 F2 · derivative.exercise_date: This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 22:46 UTC |
Peltz Stuart WalterDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 55,000 | $0.00 Strike: $33.02 | $0.00 |
DisclosureSEC source: 0001104659-19-003198 · a4.xml · derivative · entry 3 Peltz Stuart Walter · CIK 0001578962 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2029-01-21 F3 · derivative.exercise_date: This option was granted on January 22, 2019 and vests over four years, with 50% of the shares underlying the option vesting on January 22, 2022, and the remaining 50% of the original number of shares underlying the option vesting on January 22, 2023. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 22:46 UTC |
Peltz Stuart WalterDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 265,000 | $0.00 Strike: $33.02 | $0.00 |
DisclosureSEC source: 0001104659-19-003198 · a4.xml · derivative · entry 2 Peltz Stuart Walter · CIK 0001578962 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,000 Underlying: Common Stock · 265,000 shares Expires 2029-01-21 F2 · derivative.exercise_date: This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 22:46 UTC |
Peltz Stuart WalterDirector · Chief Executive Officer
|
GrantCommon Stock | 4,620 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-003198 · a4.xml · nonDerivative · entry 1 Peltz Stuart Walter · CIK 0001578962 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 22,158 F1 · shares: Restricted stock award granted on January 22, 2019 that vests in four equal installments over four years, commencing on January 22, 2020. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 22:45 UTC |
Almstead Neil GregoryChief Technical Ops Officer
|
GrantStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $33.02 | $0.00 |
DisclosureSEC source: 0001104659-19-003197 · a4.xml · derivative · entry 3 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Common Stock · 17,500 shares Expires 2029-01-21 F3 · derivative.exercise_date: This option was granted on January 22, 2019 and vests over four years, with 50% of the shares underlying the option vesting on January 22, 2022, and the remaining 50% of the original number of shares underlying the option vesting on January 22, 2023. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 22:45 UTC |
Almstead Neil GregoryChief Technical Ops Officer
|
GrantStock Option (Right to Buy) · Derivative | 72,500 | $0.00 Strike: $33.02 | $0.00 |
DisclosureSEC source: 0001104659-19-003197 · a4.xml · derivative · entry 2 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,500 Underlying: Common Stock · 72,500 shares Expires 2029-01-21 F2 · derivative.exercise_date: This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 22:45 UTC |
Almstead Neil GregoryChief Technical Ops Officer
|
GrantCommon Stock | 570 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-003197 · a4.xml · nonDerivative · entry 1 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 6,219 F1 · shares: Restricted stock unit granted on January 22, 2019 that vests in four equal installments over four years, commencing on January 22, 2020. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 22:45 UTC |
Souza MarcioChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 6,825 | $0.00 Strike: $33.02 | $0.00 |
DisclosureSEC source: 0001104659-19-003196 · a4.xml · derivative · entry 4 Souza Marcio · CIK 0001707657 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 6,825 Underlying: Common Stock · 6,825 shares Expires 2029-01-21 F2 · derivative.exercise_date: This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 22:45 UTC |
Souza MarcioChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $33.02 | $0.00 |
DisclosureSEC source: 0001104659-19-003196 · a4.xml · derivative · entry 3 Souza Marcio · CIK 0001707657 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2029-01-21 F3 · derivative.exercise_date: This option was granted on January 22, 2019 and vests over four years, with 50% of the shares underlying the option vesting on January 22, 2022, and the remaining 50% of the original number of shares underlying the option vesting on January 22, 2023. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 22:45 UTC |
Souza MarcioChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 112,500 | $0.00 Strike: $33.02 | $0.00 |
DisclosureSEC source: 0001104659-19-003196 · a4.xml · derivative · entry 2 Souza Marcio · CIK 0001707657 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,500 Underlying: Common Stock · 112,500 shares Expires 2029-01-21 F2 · derivative.exercise_date: This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 22:45 UTC |
Souza MarcioChief Operating Officer
|
GrantCommon Stock | 1,925 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-003196 · a4.xml · nonDerivative · entry 1 Souza Marcio · CIK 0001707657 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 4,667 F1 · shares: Restricted stock unit granted on January 22, 2019 that vests in four equal installments over four years, commencing on January 22, 2020. Read SEC document |
| January 07, 2019 Filed Jan 9, 2019 22:09 UTC |
Peltz Stuart WalterDirector · Chief Executive Officer
|
SaleCommon Stock | 409 | $34.75 | $14,212.75 |
DisclosureSEC source: 0001070081-19-000009 · wf-form4_154707175413809.xml · nonDerivative · entry 3 Peltz Stuart Walter · CIK 0001578962 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 17,538 F5 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 1,312 shares of restricted stock from a January 3, 2018 grant of 5,250 shares of restricted stock. F4 · ownership.nature: The reporting person acquired beneficial ownership of these securities upon his marriage to the owner of the securities in 2018. Read SEC document |
| January 07, 2019 Filed Jan 9, 2019 22:09 UTC |
Peltz Stuart WalterDirector · Chief Executive Officer
|
SaleCommon Stock | 339 | $34.75 | $11,780.25 |
DisclosureSEC source: 0001070081-19-000009 · wf-form4_154707175413809.xml · nonDerivative · entry 2 Peltz Stuart Walter · CIK 0001578962 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 17,947 F2 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 975 RSUs from a January 3, 2017 grant of 3,900 RSUs. F3 · balance_after: Includes: 1) 1,950 unvested RSUs from an award of 3,900 RSUs granted on January 3, 2017, which vests in four equal annual installments over four years, commencing on January 3, 2018; and 2) 5,250 shares of restricted stock granted on January 3, 2018, which vest in four equal annual installments over four years, commencing on January 3, 2019. F4 · ownership.nature: The reporting person acquired beneficial ownership of these securities upon his marriage to the owner of the securities in 2018. Read SEC document |
| January 07, 2019 Filed Jan 9, 2019 22:09 UTC |
Peltz Stuart WalterDirector · Chief Executive Officer
|
SaleCommon Stock | 1,764 | $34.75 | $61,299.00 |
DisclosureSEC source: 0001070081-19-000009 · wf-form4_154707175413809.xml · nonDerivative · entry 1 Peltz Stuart Walter · CIK 0001578962 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,882 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 5,400 shares of restricted stock from a January 3, 2017 grant of 21,600 shares of restricted stock. Read SEC document |
| January 07, 2019 Filed Jan 9, 2019 22:14 UTC |
Almstead Neil GregoryChief Technical Ops Officer
|
SaleCommon Stock | 68 | $34.75 | $2,363.00 |
DisclosureSEC source: 0001070081-19-000012 · wf-form4_154707207004473.xml · nonDerivative · entry 4 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 5,649 F6 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 218 RSUs from a January 3, 2018 grant of 874 RSUs. Read SEC document |
| January 07, 2019 Filed Jan 9, 2019 22:14 UTC |
Almstead Neil GregoryChief Technical Ops Officer
|
SaleCommon Stock | 55 | $34.75 | $1,911.25 |
DisclosureSEC source: 0001070081-19-000012 · wf-form4_154707207004473.xml · nonDerivative · entry 3 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 5,717 F5 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 180 RSUs from a January 3, 2017 grant of 720 RSUs. Read SEC document |
| January 07, 2019 Filed Jan 9, 2019 22:14 UTC |
Almstead Neil GregoryChief Technical Ops Officer
|
SaleCommon Stock | 57 | $34.75 | $1,980.75 |
DisclosureSEC source: 0001070081-19-000012 · wf-form4_154707207004473.xml · nonDerivative · entry 2 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 5,772 F3 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 187 RSUs from a January 4, 2016 grant of 750 RSUs. F4 · balance_after: Includes 704 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2018. Read SEC document |
| January 07, 2019 Filed Jan 9, 2019 22:14 UTC |
Almstead Neil GregoryChief Technical Ops Officer
|
SaleCommon Stock | 473 | $34.75 | $16,436.75 |
DisclosureSEC source: 0001070081-19-000012 · wf-form4_154707207004473.xml · nonDerivative · entry 1 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,396 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 1,500 shares of restricted stock from a January 3, 2017 grant of 6,000 shares of restricted stock. F2 · balance_after: Includes 715 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2018. Read SEC document |
| January 07, 2019 Filed Jan 9, 2019 22:12 UTC |
Souza MarcioChief Operating Officer
|
SaleCommon Stock | 83 | $34.75 | $2,884.25 |
DisclosureSEC source: 0001070081-19-000011 · wf-form4_154707195442272.xml · nonDerivative · entry 1 Souza Marcio · CIK 0001707657 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 2,742 F1 · kind: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 269 RSUs from a January 3, 2018 grant of 1,079 RSUs. F2 · balance_after: Includes 715 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2018 and 368 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2018. Read SEC document |
| January 07, 2019 Filed Jan 9, 2019 22:11 UTC |
Utter Christine MariePrincipal Financial Officer
|
SaleCommon Stock | 297 | $34.75 | $10,320.75 |
DisclosureSEC source: 0001070081-19-000010 · wf-form4_154707186908284.xml · nonDerivative · entry 1 Utter Christine Marie · CIK 0001707685 · Principal Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,446 F1 · kind: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 975 RSUs from a January 3, 2017 grant of 3,900 RSUs. F2 · balance_after: Includes 715 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2018 and 368 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2018. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 13:43 UTC |
Reeve EmmaDirector
|
GrantStock Option (Right To Buy) · Derivative | 1,167 | $0.00 Strike: $33.63 | $0.00 |
DisclosureSEC source: 0001070081-18-000085 · wf-form4_154514061932562.xml · derivative · entry 2 Reeve Emma · CIK 0001680329 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,167 Underlying: Common Stock · 1,167 shares Expires 2028-12-13 Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 13:43 UTC |
Reeve EmmaDirector
|
GrantStock Option (Right To Buy) · Derivative | 14,000 | $0.00 Strike: $33.63 | $0.00 |
DisclosureSEC source: 0001070081-18-000085 · wf-form4_154514061932562.xml · derivative · entry 1 Reeve Emma · CIK 0001680329 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2028-12-13 F1 · derivative.exercise_date: This option award vests in thirty-six approximately equal monthly installments, commencing on January 14, 2019 and continuing on each successive monthly anniversary of thereafter, ending on the third year anniversary of the grant date. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 13:46 UTC |
Okey StephanieDirector
|
GrantStock Option (Right To Buy) · Derivative | 1,167 | $0.00 Strike: $33.63 | $0.00 |
DisclosureSEC source: 0001070081-18-000087 · wf-form4_154514078641248.xml · derivative · entry 2 Okey Stephanie · CIK 0001742616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,167 Underlying: Common Stock · 1,167 shares Expires 2028-12-13 Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 13:46 UTC |
Okey StephanieDirector
|
GrantStock Option (Right To Buy) · Derivative | 14,000 | $0.00 Strike: $33.63 | $0.00 |
DisclosureSEC source: 0001070081-18-000087 · wf-form4_154514078641248.xml · derivative · entry 1 Okey Stephanie · CIK 0001742616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2028-12-13 F1 · derivative.exercise_date: This option award vests in thirty-six approximately equal monthly installments, commencing on January 14, 2019 and continuing on each successive monthly anniversary of thereafter, ending on the third year anniversary of the grant date. Read SEC document |
| June 19, 2018 Filed Jun 21, 2018 20:33 UTC |
Almstead Neil GregoryEVP Research Pharma Ops & Tech
|
Exercise / conversionStock Option (Right To Buy) · Derivative | 20,000 | $10.85 Strike: $10.85 | $217,000.00 |
DisclosureSEC source: 0001070081-18-000056 · wf-form4_152961316540176.xml · derivative · entry 5 Almstead Neil Gregory · CIK 0001578850 · EVP Research Pharma Ops & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,898 Underlying: Common Stock · 20,000 shares Expires 2023-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan. F4 · derivative.exercise_date: Currently exercisable. Read SEC document |
| June 19, 2018 Filed Jun 21, 2018 20:33 UTC |
Almstead Neil GregoryEVP Research Pharma Ops & Tech
|
SaleCommon Stock | 12,000 | $48.46 | $581,520.00 |
DisclosureSEC source: 0001070081-18-000056 · wf-form4_152961316540176.xml · nonDerivative · entry 3 Almstead Neil Gregory · CIK 0001578850 · EVP Research Pharma Ops & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,154 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan. F3 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $48.38 to $48.81 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| June 19, 2018 Filed Jun 21, 2018 20:33 UTC |
Almstead Neil GregoryEVP Research Pharma Ops & Tech
|
SaleCommon Stock | 8,000 | $48.09 | $384,720.00 |
DisclosureSEC source: 0001070081-18-000056 · wf-form4_152961316540176.xml · nonDerivative · entry 2 Almstead Neil Gregory · CIK 0001578850 · EVP Research Pharma Ops & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,154 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan. F2 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $47.58 to $48.37 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| June 19, 2018 Filed Jun 21, 2018 20:33 UTC |
Almstead Neil GregoryEVP Research Pharma Ops & Tech
|
Exercise / conversionCommon Stock | 20,000 | $10.85 | $217,000.00 |
DisclosureSEC source: 0001070081-18-000056 · wf-form4_152961316540176.xml · nonDerivative · entry 1 Almstead Neil Gregory · CIK 0001578850 · EVP Research Pharma Ops & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,154 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan. Read SEC document |
| June 01, 2018 Filed Jun 4, 2018 20:22 UTC |
Souza MarcioChief Operating Officer
|
SaleCommon Stock | 5,161 | $34.65 | $178,828.65 |
DisclosureSEC source: 0001070081-18-000052 · wf-form4_152814373741541.xml · nonDerivative · entry 1 Souza Marcio · CIK 0001707657 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,071 F1 · kind: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 15,000 shares of restricted stock from a May 31, 2017 grant of 30,000 shares. F2 · balance_after: Includes 1,112 shares acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2017 and 663 shares acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2017. Includes 30,000 shares of a restricted stock award awarded to the Reporting Person on May 31, 2017 and reported on the Form 4 filed by the Reporting Person on June 2, 2017, which shares were inadvertently not previously included in Column 5 of Table 1 on such Form 4. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 22:59 UTC |
Almstead Neil GregoryEVP Research Pharma Ops & Tech
|
SaleCommon Stock | 82 | $18.03 | $1,478.46 |
DisclosureSEC source: 0001070081-18-000031 · wf-form4_151553878007729.xml · nonDerivative · entry 2 Almstead Neil Gregory · CIK 0001578850 · EVP Research Pharma Ops & Tech 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 5,125 F3 · kind: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 188 RSUs from a January 4, 2016 grant of 750 shares. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 22:59 UTC |
Almstead Neil GregoryEVP Research Pharma Ops & Tech
|
SaleCommon Stock | 621 | $18.03 | $11,196.63 |
DisclosureSEC source: 0001070081-18-000031 · wf-form4_151553878007729.xml · nonDerivative · entry 1 Almstead Neil Gregory · CIK 0001578850 · EVP Research Pharma Ops & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,154 F1 · kind: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 1,500 shares of restricted stock from a January 3, 2017 grant of 6,000 shares. F2 · balance_after: Includes 1,112 shares acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2017 and 663 shares acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2017. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 22:59 UTC |
Peltz Stuart WalterDirector · Chief Executive Officer
|
SaleCommon Stock | 2,230 | $18.03 | $40,206.90 |
DisclosureSEC source: 0001070081-18-000030 · wf-form4_151553874031642.xml · nonDerivative · entry 1 Peltz Stuart Walter · CIK 0001578962 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,646 F1 · kind: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 5,400 shares of restricted stock from a January 3, 2017 grant of 21,600 shares. Read SEC document |
| January 04, 2018 Filed Jan 5, 2018 21:09 UTC |
Almstead Neil GregoryEVP Research Pharma Ops & Tech
|
SaleCommon Stock | 77 | $17.67 | $1,360.59 |
DisclosureSEC source: 0001070081-18-000018 · wf-form4_151518652790156.xml · nonDerivative · entry 2 Almstead Neil Gregory · CIK 0001578850 · EVP Research Pharma Ops & Tech 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 5,207 F3 · kind: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 180 RSUs from a January 3, 2017 grant of 720 shares. Read SEC document |
| January 04, 2018 Filed Jan 5, 2018 21:07 UTC |
Utter Christine MariePrincipal Financial Officer
|
SaleCommon Stock | 412 | $17.67 | $7,280.04 |
DisclosureSEC source: 0001070081-18-000016 · wf-form4_151518641813910.xml · nonDerivative · entry 1 Utter Christine Marie · CIK 0001707685 · Principal Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,660 F1 · kind: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 975 RSUs from a January 3, 2017 grant of 3,900 shares. F2 · balance_after: Includes 1,112 shares acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2017 and 663 shares acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2017. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 21:17 UTC |
STEELE GLENN JR MD PHDDirector
|
GrantStock Option (Right To Buy) · Derivative | 14,000 | $0.00 Strike: $18.01 | $0.00 |
DisclosureSEC source: 0001070081-18-000025 · wf-form4_151518704257207.xml · derivative · entry 1 STEELE GLENN JR MD PHD · CIK 0001269131 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2028-01-02 F1 · derivative.exercise_date: This option was granted on January 3, 2018 and vests over one year in twelve equal monthly installments, commencing on February 3, 2018. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 21:16 UTC |
Jacobson Allan StevenDirector
|
GrantStock Option (Right To Buy) · Derivative | 14,000 | $0.00 Strike: $18.01 | $0.00 |
DisclosureSEC source: 0001070081-18-000024 · wf-form4_151518700209317.xml · derivative · entry 1 Jacobson Allan Steven · CIK 0001579003 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2028-01-02 F1 · derivative.exercise_date: This option was granted on January 3, 2018 and vests over one year in twelve equal monthly installments, commencing on February 3, 2018. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 21:16 UTC |
ZELDIS JEROME BDirector
|
GrantStock Option (Right To Buy) · Derivative | 14,000 | $0.00 Strike: $18.01 | $0.00 |
DisclosureSEC source: 0001070081-18-000023 · wf-form4_151518696647616.xml · derivative · entry 1 ZELDIS JEROME B · CIK 0001433982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2028-01-02 F1 · derivative.exercise_date: This option was granted on January 3, 2018 and vests over one year in twelve equal monthly installments, commencing on February 3, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.